Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Imarikiren by Scohia Pharma for Diabetic Nephropathy: Likelihood of Approval
Imarikiren is under clinical development by Scohia Pharma and currently in Phase II for Diabetic Nephropathy. According to GlobalData, Phase...